Table 2.
Adjusted prevalence of co-occurring substance use disorder diagnoses at delivery hospitalization in the United States, by specific substances
| Any co-occurring substance use disorder, % | Specific additional substance use disorders, % | |||||||
|---|---|---|---|---|---|---|---|---|
| Alcohol | Amphetamines | Cannabis | Cocaine | Opioids | Sedatives | Tobacco | ||
| Alcohol | 69.0 | -- | 8.0 | 23.2 | 15.9 | 7.3 | 1.0 | 50.3 |
| Amphetamines | 63.4 | 3.4 | -- | 26.2 | 4.1 | 15.0 | 2.0 | 49.3 |
| Cannabis | 55.7 | 2.1 | 6.6 | -- | 4.5 | 6.9 | 1.2 | 46.3 |
| Cocaine | 69.1 | 8.4 | 7.2 | 31.9 | -- | 25.8 | 2.6 | 54.5 |
| Opioids | 62.1 | 1.4 | 5.7 | 10.6 | 5.6 | -- | 2.5 | 57.2 |
| Sedatives | 83.7 | 3.9 | 11.9 | 31.9 | 17.2 | 38.9 | -- | 48.5 |
| Tobacco | 10.7 | 0.80 | 2.0 | 7.4 | 1.2 | 6.0 | 0.22 | -- |
Notes: From weighted logistic regression models adjusted for maternal age, race/ethnicity, rural/urban county of residence, Medicaid insurance, and year of delivery; marginal standardization was used to derive adjusted prevalence estimates. Analysis of the National Inpatient Sample, 2007-2016. Weighted N=2,770,489 delivery hospitalizations.